SCHEMBL16254602

SCHEMBL16254602

COC(=O)C1C[C@@H](Oc2ccnc3cc(OC)ccc23)CN1C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
P2RX3 P56373 1/20 0.43
MET P08581 8/20 0.40
CCNT1 O60563 1/20 0.40
CDK9 P50750 1/20 0.40
IDO1 P14902 2/20 0.40
KDR P35968 4/20 0.40
AURKA O14965 3/20 0.40
TEK Q02763 3/20 0.40
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
AURKB Q96GD4 1/20 0.38
CSF1R P07333 1/20 0.37
PDGFRB P09619 1/20 0.37
PDE4B Q07343 1/20 0.37
CYP3A4 P08684 1/20 0.36
MCL1 Q07820 2/20 0.36
MAPK7 Q13164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1943053 1.00 P2RX3 (0.43) P2RX3METCCNT1CDK9IDO1
SCHEMBL12035225 1.00 P2RX3 (0.43) P2RX3METCCNT1CDK9IDO1
SCHEMBL6805874 0.92 MET (0.41) P2RX3METIDO1KDRAURKA
SCHEMBL1942540 0.92 MET (0.41) P2RX3METIDO1KDRAURKA
SCHEMBL6805877 0.92 MET (0.41) P2RX3METIDO1KDRAURKA
SCHEMBL7394071 0.92 MET (0.41) P2RX3METIDO1KDRAURKA
SCHEMBL4983069 0.89 P2RX3 (0.47) P2RX3CCNT1CDK9IDO1KDM4E
SCHEMBL4983074 0.89 P2RX3 (0.47) P2RX3CCNT1CDK9IDO1KDM4E
SCHEMBL8348548 0.89 P2RX3 (0.47) P2RX3CCNT1CDK9IDO1KDM4E
SCHEMBL16380543 0.89 P2RX3 (0.47) P2RX3CCNT1CDK9IDO1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8889871-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2014-11-18 US disclosed